$107.22 (-1.23%)

Volume: 345.368k

Closed: Mar 31, 2023

Hollow Logo Score: -2.759
Ascendis Pharma A/S Stock
$107.22 (-1.23%)

Volume: 345.368k

Closed: Mar 31, 2023

Score Hollow Logo -2.759

Ascendis Pharma A/S Stock Company Profile

Tuborg Boulevard 12

Hellerup 2900

45 70 22 22 44


Industry: Biotechnology

Sector: Healthcare

Ascendis Pharma A/S


Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE